Julie B.
- Country
- Belgium
- Department
- Gastro-enterologie
Research Overview
- A randomized, double-blind, multicenter phase III study to evaluate the long-term efficacy and safety of ABX464 25 mg or 50 mg once daily as a maintenance therapy in subjects with moderately to severely active ulcerative colitis
- A Study to Test How Well Obefazimod Works and How Safe It Is for Patients with Moderately to Severely Active Ulcerative Colitis
- Long‑Term Safety and Efficacy of SPY001‑001 Monotherapy and Combination Therapy with Long‑Acting Antibodies in Adults with Ulcerative Colitis
Data & Insights
Has run more than one trial at 161 of 308 partner sites.
Specializations
Inflammatory Bowel Disease Management
The investigator specializes in treating inflammatory bowel diseases, with particular emphasis on both ulcerative colitis and Crohn's disease.
- Moderate to Severe Ulcerative Colitis Treatment
- Crohn's Disease Post-Operative Care
- Long-term Disease Management
Their research explores innovative therapeutic approaches for managing chronic inflammatory conditions of the digestive system.
Novel Therapeutic Investigations
The investigator focuses on evaluating emerging treatment modalities and their effectiveness in achieving clinical remission in inflammatory bowel conditions.
- Biological Therapy Assessment
- Treatment Response Evaluation
- Therapeutic Maintenance Strategies
Their work encompasses both short-term efficacy assessment and long-term therapeutic monitoring.
Post-Surgical Care Research
The investigator studies post-operative disease management with particular attention to preventing recurrence in surgical patients.
- Endoscopic Recurrence Prevention
- Post-Surgical Monitoring
- Risk Factor Assessment
Their research addresses the specific needs of patients requiring surgical intervention for inflammatory bowel conditions.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.